Please login to the form below

Not currently logged in
Email:
Password:

Vertex Pharmaceuticals

This page shows the latest Vertex Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Grey Wolf secures £10m Series A to ‘illuminate’ tumour cells

Grey Wolf secures £10m Series A to ‘illuminate’ tumour cells

cells. CEO and co-founder Peter Joyce. The company, which was founded by ex-Vertex exec Peter Joyce and Spinifex Pharmaceuticals' former CEO Tom McCarthy, says the science behind the tech

Latest news

More from news
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    The biggest movers in respiratory were Teva (26%) and Vertex Pharmaceuticals (23.7%). ... Vertex has two - with Kalydeco sitting alongside Orkambi in an impressive respiratory portfolio.”.

  • Deal Watch March 2017 Deal Watch March 2017

    Vertex paid $160m in cash to Concert Pharmaceuticals to purchase the assets of CTP-656, and could pay an additional $90m in milestones based on regulatory approval and reimbursement. ... 250. Concert Pharmaceuticals. Vertex Pharmaceuticals. Product

  • Using social data to see patients more clearly Using social data to see patients more clearly

    This kind of information would have thrilled executives at Vertex Pharmaceuticals, the makers of Orkambi - and worried their competitors.

  • Deal Watch October 2015 Deal Watch October 2015

    17, 200. CRISPR Therapeutics/ Vertex Pharmaceuticals. CRISPR-Cas9 gene editing technology for discovery of new treatments for genetic diseases incl sickle cell disease, CF. ... Collaboration, option to license. 339. Regeneron Pharmaceuticals/ Mitsubishi

  • Orphan indication? No easy access Orphan indication? No easy access

    a series of incentives (including protocol assistance, extended market exclusivity, changes to the fee structure for registration) for the development of pharmaceuticals with orphan designation. ... found. Governments also step in in some instances, for

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Hanover Brussels appoints Aurélie Marchand as account director Hanover Brussels appoints Aurélie Marchand as account director

    In her new role, Marchand will report to Eatwell and she will oversee the group’s portfolio of clients, which includes Sanofi Pasteur and Vertex Pharmaceuticals.

  • Rubius Therapeutics strengthens senior team Rubius Therapeutics strengthens senior team

    His experience includes establishing the legal department at Millennium Pharmaceuticals - now Takeda Oncology - and served as its associate general counsel and chief patent counsel for several years. ... He has spent 16 years at Novartis holding roles in

  • Vertex poaches new finance chief from Ironwood Pharmaceuticals Vertex poaches new finance chief from Ironwood Pharmaceuticals

    Boston-based biotech company appoints Tom Graney. Vertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer. ... Tom has the ideal blend of financial acumen, leadership skills,

  • Ironwood Pharmaceuticals appoints chief development officer Ironwood Pharmaceuticals appoints chief development officer

    Dr Christopher Wright joins from Axcella Health. Ironwood Pharmaceuticals has appointed Dr Christopher Wright as its new senior vice president of global development and chief development officer in a role that ... affairs for Vertex Pharmaceuticals.

  • Proteostasis Therapeutics strengthens leadership team Proteostasis Therapeutics strengthens leadership team

    Dr Gilmartin joins from AstraZeneca, where he most recently served as its senior medical lead for global medicines development, and has previously worked at Vertex Pharmaceuticals and Beth Israel Deaconess Medical ... Center. Chhabra said: “Geoffrey's

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics